Detailed information for compound 917610

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 335.378 | Formula: C15H17N3O4S
  • H donors: 3 H acceptors: 3 LogP: 1.91 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)NNS(=O)(=O)c1ccc(cc1)NC(=O)C
  • InChi: 1S/C15H17N3O4S/c1-11(19)16-12-5-9-15(10-6-12)23(20,21)18-17-13-3-7-14(22-2)8-4-13/h3-10,17-18H,1-2H3,(H,16,19)
  • InChiKey: XQBPLHDYONJVBX-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens indoleamine 2,3-dioxygenase 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi indoleamine 2,3-dioxygenase Get druggable targets OG5_130288 All targets in OG5_130288
Schistosoma japonicum ko:K00463 indoleamine 2,3-dioxygenase, putative Get druggable targets OG5_130288 All targets in OG5_130288
Schistosoma mansoni hypothetical protein Get druggable targets OG5_130288 All targets in OG5_130288
Schistosoma mansoni hypothetical protein Get druggable targets OG5_130288 All targets in OG5_130288
Schistosoma japonicum IPR000898,Indoleamine 2,3-dioxygenase,domain-containing Get druggable targets OG5_130288 All targets in OG5_130288
Candida albicans similar to indoleamine 2,3-dioxygenases Get druggable targets OG5_130288 All targets in OG5_130288
Loa Loa (eye worm) indoleamine 2,3-dioxygenase Get druggable targets OG5_130288 All targets in OG5_130288
Candida albicans similar to indoleamine 2,3-dioxygenases Get druggable targets OG5_130288 All targets in OG5_130288
Echinococcus multilocularis indoleamine 2,3 dioxygenase 2 Get druggable targets OG5_130288 All targets in OG5_130288
Echinococcus granulosus indoleamine 23 dioxygenase 2 Get druggable targets OG5_130288 All targets in OG5_130288

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni voltage-gated potassium channel 0.0012 0.0088 0.0088
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0012 0.0088 0.0088
Loa Loa (eye worm) cyclic-nucleotide gated cation channel 0.0008 0.0031 0.0031
Echinococcus multilocularis mitogen activated protein kinase kinase kinase 0.0057 0.0769 0.0769
Loa Loa (eye worm) STE/STE20/KHS protein kinase 0.0057 0.0769 0.0769
Brugia malayi Cyclic-nucleotide gated cation channel 0.0008 0.0031 0.0031
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog 0.0041 0.0533 0.0533
Echinococcus granulosus Serine/threonine-protein kinase Genghis Khan 0.0057 0.0769 0.0769
Echinococcus multilocularis mitogen activated protein kinase kinase kinase 0.0057 0.0769 0.0769
Onchocerca volvulus 0.0056 0.0758 0.5
Echinococcus granulosus serine:threonine protein kinase mig 15 0.019 0.2786 0.2786
Schistosoma mansoni voltage-gated potassium channel 0.0045 0.059 0.059
Loa Loa (eye worm) hypothetical protein 0.0056 0.0758 0.0758
Schistosoma mansoni mitogen-activated protein kinase kinase kinase 3 mapkkk3 mekk3 0.0056 0.0758 0.0758
Schistosoma mansoni 60S ribosomal protein L21 0.0007 0.0006 0.0006
Echinococcus multilocularis cyclic nucleotide gated cation channel alpha 3 0.0008 0.0031 0.0031
Echinococcus multilocularis potassium:sodium hyperpolarization activated 0.0008 0.0031 0.0031
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0039 0.0492 1
Schistosoma mansoni voltage-gated potassium channel 0.0008 0.0031 0.0031
Schistosoma mansoni hypothetical protein 0.0667 1 1
Echinococcus granulosus cyclic nucleotide gated cation channel alpha 3 0.0008 0.0031 0.0031
Echinococcus granulosus hyperpolarization activated cyclic 0.0008 0.0031 0.0031
Echinococcus multilocularis voltage gated potassium channel 0.0012 0.0088 0.0088
Trypanosoma cruzi Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative 0.0056 0.0758 0.5
Echinococcus granulosus protein kinase 0.0135 0.1945 0.1945
Schistosoma mansoni protein kinase 0.0135 0.1945 0.1945
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0041 0.0533 0.0533
Loa Loa (eye worm) hypothetical protein 0.0036 0.045 0.045
Echinococcus granulosus mitogen activated protein kinase kinase kinase 0.0057 0.0769 0.0769
Leishmania major protein kinase, putative 0.0006 0 0.5
Brugia malayi probable protein kinase 0.0191 0.2796 0.2796
Schistosoma mansoni hypothetical protein 0.0667 1 1
Echinococcus granulosus cyclic nucleotide gated cation channel 0.0008 0.0031 0.0031
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0008 0.0031 0.0031
Echinococcus multilocularis indoleamine 2,3 dioxygenase 2 0.0667 1 1
Trypanosoma brucei Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative 0.0056 0.0758 0.5
Brugia malayi Temporarily assigned gene name protein 59 0.0056 0.0758 0.0758
Schistosoma mansoni voltage-gated potassium channel 0.0045 0.059 0.059
Toxoplasma gondii protein kinase G AGC kinase family member PKG 0.0006 0 0.5
Plasmodium falciparum cGMP-dependent protein kinase 0.0006 0 0.5
Schistosoma mansoni protein kinase 0.0191 0.2796 0.2796
Brugia malayi Protein kinase domain containing protein 0.0057 0.0769 0.0769
Leishmania major protein kinase, putative 0.0006 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0012 0.0088 0.0088
Schistosoma mansoni serine/threonine protein kinase 0.0057 0.0769 0.0769
Schistosoma mansoni voltage-gated potassium channel 0.0012 0.0088 0.0088
Loa Loa (eye worm) voltage and ligand gated potassium channel 0.0041 0.0533 0.0533
Loa Loa (eye worm) hypothetical protein 0.0056 0.0758 0.0758
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0012 0.0088 0.0088
Echinococcus granulosus voltage gated potassium channel 0.0012 0.0088 0.0088
Loa Loa (eye worm) hypothetical protein 0.019 0.2786 0.2786
Schistosoma mansoni serine/threonine protein kinase 0.0057 0.0769 0.0769
Echinococcus multilocularis 0.0135 0.1945 0.1945
Schistosoma mansoni rap gtpase-activating protein 0.0056 0.0758 0.0758
Echinococcus granulosus potassium:sodium hyperpolarization activated 0.0008 0.0031 0.0031
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0041 0.0533 0.0533
Brugia malayi Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog 0.0012 0.0088 0.0088
Loa Loa (eye worm) cyclic-nucleotide gated cation channel 0.0008 0.0031 0.0031
Echinococcus multilocularis cyclic nucleotide gated cation channel 0.0008 0.0031 0.0031
Schistosoma mansoni hyperpolarization activated cyclic nucleotide-gated potassium channel 0.0008 0.0031 0.0031
Schistosoma mansoni hypothetical protein 0.0056 0.0758 0.0758
Schistosoma mansoni vam6/vps39 related 0.0056 0.0758 0.0758
Echinococcus multilocularis serine:threonine protein kinase MRCK beta 0.0057 0.0769 0.0769
Loa Loa (eye worm) hypothetical protein 0.0008 0.0031 0.0031
Loa Loa (eye worm) hypothetical protein 0.0056 0.0758 0.0758
Brugia malayi hypothetical protein 0.0056 0.0758 0.0758
Echinococcus granulosus cyclic nucleotide gated cation channel 0.0008 0.0031 0.0031
Echinococcus granulosus indoleamine 23 dioxygenase 2 0.0667 1 1
Echinococcus granulosus mitogen activated protein kinase kinase kinase 0.0057 0.0769 0.0769
Schistosoma mansoni voltage-gated potassium channel 0.0007 0.0006 0.0006
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0008 0.0031 0.0031
Schistosoma mansoni mitogen-activated protein kinase kinase kinase 3 mapkkk3 mekk3 0.0056 0.0758 0.0758
Echinococcus granulosus Vam6:Vps39 protein 0.0056 0.0758 0.0758
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0008 0.0031 0.0031
Echinococcus granulosus GTPase activating Rap:RanGAP domain 3 0.0056 0.0758 0.0758
Schistosoma mansoni hyperpolarization activated cyclic nucleotide-gated potassium channel 0.0008 0.0031 0.0031
Trypanosoma cruzi Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative 0.0056 0.0758 0.5
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0039 0.0492 1
Echinococcus multilocularis hyperpolarization activated cyclic 0.0008 0.0031 0.0031
Echinococcus granulosus hyperpolarization activated cyclic 0.0008 0.0031 0.0031
Loa Loa (eye worm) STE/STE20/MSN protein kinase 0.0135 0.1945 0.1945
Echinococcus multilocularis hyperpolarization activated cyclic 0.0008 0.0031 0.0031
Schistosoma mansoni protein kinase 0.0057 0.0769 0.0769
Loa Loa (eye worm) indoleamine 2,3-dioxygenase 0.0667 1 1
Echinococcus multilocularis GTPase activating Rap:RanGAP domain 3 0.0056 0.0758 0.0758

Activities

Activity type Activity value Assay description Source Reference
EC50 (binding) > 10000 nM Inhibition of IDO in human HeLa cells after 24 hrs by spectrophotometry ChEMBL. 24939758
IC50 (binding) = 254 nM Inhibition of human recombinant IDO expressed in Escherichia coli using N-formylkynurenine as substrate incubated for 1 hr prior to NaOH addition measured after 4 hrs by spectrophotometry ChEMBL. 24939758

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.